Scientific and Medical Advisory Council

The Scientific and Medical Advisory Council (SMAC) provides the collective voice and leadership for the Crohn’s and Colitis Canada IBD Research Institute (IBDRI). 

Crohn’s and Colitis Canada relies on guidance from this group of experts as it strives to deliver on its mission to find the cures for Crohn's disease and ulcerative colitis and improve the lives of children and adults affected by these diseases.

The 2017/2018 SMAC includes:

Members Institution
Dr. Mark Silverberg, Chair  University of Toronto, Mount Sinai Hospital
Dr. John Rioux, Vice-Chair  Université de Montréal & Montreal Heart Institute
Dr. Laura Sly University of British Columbia, BC Children's Hospital
Dr. Tony Otley Dalhousie University
Dr. John Marshall McMaster University Medical Centre
Dr. Gil Kaplan Insitute of Public Health, University of Calgary
Dr. Nicola Jones University of Toronto, The Hospital for Sick Children
Dr. Eric Benchimol University of Ottawa, Children's Hospital of Eastern Ontario
Dr. Brian Bressler University of British Columbia, St. Paul's Hospital 
 
 

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 150 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest